Related Experiment Video
Updated: Jul 19, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis
Jagruti H Patel1, Steven B McMahon
1Biomedical Graduate Studies, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Abstract:
The c-MYC oncoprotein is among the most potent transforming agents in human cells. Ironically, c-MYC is also capable of inducing massive apoptosis under certain conditions. A clear understanding of the distinct pathways activated by c-MYC during apoptosis induction and transformation is crucial to the design of therapeutic strategies aimed at selectively reactivating the apoptotic potential of c-MYC in cancer cells. We recently demonstrated that apoptosis induction in primary human cells strictly requires that c-MYC bind and inactivate the transcription factor MIZ-1. This presumably blocked the ability of MIZ-1 to activate the transcription of an unidentified pro-survival gene. Here we report that MIZ-1 activates the transcription of BCL2. More importantly, inhibition of the MIZ-1/BCL2 signal is an essential event during the apoptotic response. Furthermore, targeting BCL2 with short hairpin RNA or small molecule inhibitors restores the apoptotic potential of a c-MYC mutant that is defective for MIZ-1 inhibition. These observations suggest that repression of BCL2 transcription is the single essential consequence of targeting the MIZ-1 pathway during apoptosis induction. These data define a genetic pathway that helps to explain historical observations documenting cooperation between c-MYC and BCL2 overexpression in human cancer.
Insights
The c-MYC oncoprotein can trigger cell death by inhibiting the transcription factor MIZ-1, which normally promotes survival by activating BCL2. Targeting this MIZ-1/BCL2 pathway reactivates c-MYC
Area of Science:
- Molecular oncology
- Cell death pathways
- Cancer biology
Background:
- The c-MYC oncoprotein drives cell transformation but can also induce apoptosis.
- Understanding c-MYC's distinct pathway activation in apoptosis versus transformation is key for cancer therapy.
- Previous work showed c-MYC-induced apoptosis requires MIZ-1 inactivation.
Purpose of the Study:
- To identify the pro-survival gene regulated by MIZ-1.
- To elucidate the role of the MIZ-1/BCL2 pathway in c-MYC-mediated apoptosis.
- To explore therapeutic strategies targeting this pathway.
Main Methods:
- Investigated the interaction between c-MYC and MIZ-1.
- Analyzed gene expression changes, specifically BCL2 transcription.
- Utilized short hairpin RNA (shRNA) and small molecule inhibitors against BCL2.
- Assessed the apoptotic potential of a MIZ-1-defective c-MYC mutant.
Main Results:
- MIZ-1 directly activates the transcription of the pro-survival gene BCL2.
- Inhibition of the MIZ-1/BCL2 signaling axis is essential for c-MYC-induced apoptosis.
- Targeting BCL2 with shRNA or inhibitors restored apoptosis in cells with a MIZ-1-inhibitory defective c-MYC mutant.
Conclusions:
- Repression of BCL2 transcription is a critical outcome of MIZ-1 pathway targeting during c-MYC-induced apoptosis.
- This defines a genetic pathway linking c-MYC, MIZ-1, and BCL2 in apoptosis.
- These findings explain the cooperation between c-MYC and BCL2 in cancer development.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

